
Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.
Plan and execute CDMA activities in Japan according to TA strategy, focusing on Obesity disease and MASH. Collaborate with external experts, build new scientific evidence, and prepare Integrated Asset Plan and Detailed Annual Communication Plan.
Boehringer Ingelheim is a global pharmaceutical leader with over 53,000 employees dedicated to advancing health through innovation. Specializing in human and animal healthcare, the company offers a range of products including biopharmaceuticals, contract manufacturing, and research services. Committed to improving lives worldwide, Boehringer Ingelheim's collaborative culture drives breakthroughs in pharmaceutical science.

Boehringer Ingelheim